ClinicalTrials.gov
ClinicalTrials.gov Menu

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients (IoN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01398085
Recruitment Status : Recruiting
First Posted : July 20, 2011
Last Update Posted : October 26, 2016
Sponsor:
Collaborator:
Cancer Research UK
Information provided by (Responsible Party):
University College, London

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : November 2020
  Estimated Study Completion Date : January 2021